Last reviewed · How we verify
Uveitis
Approved treatments
- prednisolon · Hannover Medical School
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Lotemax · Bausch Health
- Tobi · Novartis
- Fml · AbbVie
- Klaron · Merck & Co.
- Medrifar · AbbVie
- Cortone
- Lotemax · Tufts Medical Center
- Decadron · Generic (originally Merck)
- Vantobra · Pfizer
- Cortef · Generic (originally Merck/Upjohn)
- Nebcin · University Hospital, Lille
- Cortisporin · Pfizer
- Rodinolone
- Cortisporin · Pfizer
- Flarex · Harrow Health
- Homatropin
- Benzododecinium
- Infliximab [infliximab biosimilar 3] · Pfizer
Infliximab biosimilar 3 is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha) to treat inflammatory conditions. - Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- scopolamin · University Hospital, Angers
Clinical guidelines
- FDA label — 1L|2L
Treatment of non-infectious intermediate, posterior, and panuveitis in adult patients.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Uveitis patent landscape — cliff calendar, originator estates, attackable patents
- Uveitis treatment landscape brief
- Uveitis treatment updates RSS
Frequently asked questions about Uveitis
What drugs treat Uveitis?
Tracked treatments include prednisolon, Ramycin, Lotemax, Tobi, Fml, Klaron, Medrifar, Cortone.
What is the treatment for Uveitis?
Standard treatment for Uveitis includes prednisolon, Ramycin, Lotemax, Tobi, Fml. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Uveitis?
FDA label publishes guidelines for Uveitis. 1 guideline references tracked.
Related
- Treatment landscape: Uveitis patent cliff · Uveitis CI report
- Treatment: prednisolon · Hannover Medical School
- Treatment: Ramycin
- Treatment: Lotemax · Bausch Health
- Treatment: Tobi · Novartis
- Treatment: Fml · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing